Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Items for the Week Previous | All Articles This Week | Next
This article originally posted and appeared in  Safety and Error PreventionMedical DevicesPublic HealthIssue 650

Airport Full-Body Scans Can Cause Malfunction of Insulin Pumps and CGMS Systems

A new report suggests people with diabetes who wear an insulin pump or a continuous glucose monitoring device may encounter a problem when going through a full-body scanning machine....

Advertisement

As the authors of the report note, insulin pumps and continuous glucose monitoring devices are at risk of electromagnetic malfunction if they are taken through imaging devices. More specifically, here is a list of diabetic medical devices and imaging equipment that may cause interference:

  • Insulin pumps, continuous glucose monitors, continuous glucose monitor transmitters, and the iPro Recorder (from Medtronic) can be affected by computer-assisted tomography (CAT), x-rays, magnetic resonance imaging (MRI), positron emission tomography (PET), and airport body scanners.
  • All of these same medical devices are not affected by airport metal detectors

To be safe, therefore, anyone who has any of these devices should opt out of full-body scans and request a pat-down or to be checked with a regular metal detector. Medtronic, for example, provides patients with Airport Security Guidelines which explain that their continuous glucose monitoring devices and pumps can be taken through metal detection but that both devices must be removed if patients go through a full-body scanner.

The company also provides patients with information cards that can be shown to TSA screeners. Another pump manufacturer, Animas Corporation, recommends patients avoid exposing their pumps to x-rays and ask for a hand-wand inspection. Insulet Corp. has a pump system that uses a technology that makes it theoretically immune from electromagnetic problems.

The possibility that going through airport security could impact and damage insulin pumps brings to mind another security issue regarding insulin pumps and other implanted medical devices. Numerous experts have been investigating the possibility that hackers can remotely infiltrate insulin pumps, pacemakers, and other healthcare technology, causing them to malfunction.

So while advances in medical technology are helping improve the lives of individuals who have serious health issues, they also have the potential to makes those lives more complicated. For people who have insulin pumps or sensors, precautions should be taken when traveling to help ensure these critical medical devices don't become victims of airport security.

Cornish A, Chase H. Peter. Navigating airport security with an insulin pump and/or sensor. Diabetes Technology & Therapeutics Oct 2012, doi:10.1089/dia.2012.0220 

Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 02 November, 2012 and appeared in  Safety and Error PreventionMedical DevicesPublic HealthIssue 650

Past five issues: Issue 796 | Diabetes Clinical Mastery Series Issue 255 | Issue 795 | SGLT-2 Inhibitors Special Edition August 2015 | Diabetes Clinical Mastery Series Issue 254 |

2015 Most Popular Articles:

Coffee Consumption Proves Potential in Reducing Type 2 Diabetes Risk
Posted August 07, 2015
Impaired Glucose Uptake in the Brain May Increase Alzheimer's Disease Risk
Posted August 07, 2015
First Non-Surgical Weight Loss Procedure for Mild-to-Moderate Obesity
Posted August 07, 2015
GLP-1 Agonist Semaglutide Completes Phase III Trial with Positive Results
Posted August 07, 2015
Ketoacidosis Not as Great as Thought in Diabetes Patients Taking Invokana
Posted August 13, 2015
Impact of Switching Insulin Glargine to Insulin Detemir in T2 Patients
Posted August 14, 2015
SIgnificant Weight Gain Associated with Laparoscopic Sleeve Gastrectomy
Posted August 14, 2015
Two New Possible Methods for Diagnosing and Monitoring Diabetes
Posted August 07, 2015
Diabetes Combination Drug LixiLan Meets Main Target in Late Stage Trial
Posted August 07, 2015
Soybean Oil Causes More Obesity and Diabetes Than Fructose
Posted August 20, 2015


Browse by Feature Writer & Article Category.
A. Lee Dellon, MD | Aaron I. Vinik, MD, PhD, FCP, MACP | Beverly Price | Charles W Martin, DD | Derek Lowe, PhD | Dr. Brian Jakes, Jr. | Dr. Fred Pescatore | Dr. Tom Burke, Ph.D | Eric S. Freedland | Evan D. Rosen | Ginger Kanzer-Lewis | Greg Milliger | Kristina Sandstedt | Laura Plunkett | Leonard Lipson, M.A. | Louis H. Philipson | Maria Emanuel Ryan, DDS, PhD | Marilyn Porter, RD, CDE | Melissa Diane Smith | Michael R. Cohen, RPh, MS, ScD, FASHP | Paul Chous, M.A., OD | Philip A. Wood PhD | R. Keith Campbell, Professor, B.Pharm, MBA, CDE | Richard K. Bernstein, MD | Sheri R. Colberg PhD | Sherri Shafer | Stanley Schwartz, MD, FACP, FACE | Steve Pohlit | Steven V. Edelman, M.D. | Timothy S. Hollingshead |

Cast Your Vote
What percentage of your patients have reached goal for A1c, BP and cholesterol?

CME/CE of the Week
Ken Mahaffey, MD, and Matthew T. Roe, MD, MHS

Category: Cardiology
Credits:
 1